AI assistant
Fagron N.V. — Earnings Release 2013
Apr 15, 2013
3949_iss_2013-04-15_2b7a2b9c-dfc2-48f0-97a5-6886068c7478.pdf
Earnings Release
Open in viewerOpens in your device viewer
Press release Regulated information
CHANGE TO METHOD OF CALCULATING TURNOVER GROWTH AT CONSTANT EXCHANGE RATES
Waregem (Belgium) / Rotterdam (Netherlands)1 , 15 April 2013 – Arseus announces that it decided to change its method of calculating total and organic turnover growth at constant exchange rates as from 30 June 2013.
At the beginning of 2012, after acquisitions in the United States and Brazil – its first acquisitions outside Europe – Arseus started publishing total and organic turnover growth figures at constant exchange rates. In the method consistently applied by Arseus, this has been based on the exchange rate on 31 December of the previous year. However, this method can give a distorted view of operational developments at Arseus and in particular at its Fagron division. After consulting investors and analysts, the Board of Directors has therefore decided to change the calculation method.
As from 30 June 2013, the calculation of total and organic turnover growth at constant exchange rates of Arseus and its Fagron division in a given period will be based on the average exchange rate in the same period of the previous year.
To enable comparison of future total and organic turnover growth at constant exchange rates of Arseus and its Fagron division, Arseus has calculated total and organic turnover growth at constant exchange rates in the first quarter of 2013 and the four quarters of 2012 using the new method described above. For Arseus, both total growth and organic growth at constant exchange rates, as calculated by this method, were 3.9% in the first quarter of 2013. For Fagron, total growth at constant exchange rates was 8.5% and organic growth at constant exchange rates was 8.4%.
1 This press release was sent out by Arseus NV and Arseus BV.
| 1st quarter 2013 | Total growth | Total growth constant rates |
Org. growth | Org. growth constant rates |
|---|---|---|---|---|
| Fagron | 4.3% | 8.5% | 4.3% | 8.4% |
| Arseus | 1.7% | 3.9% | 1.7% | 3.9% |
| 2012 | Total growth | Total growth | Org. growth | Org. growth |
|---|---|---|---|---|
| constant rates | constant rates | |||
| 1 st quarter |
||||
| Fagron | 33.7% | 34.4% | 8.0% | 8.6% |
| Arseus | 17.7% | 17.9% | 6.1% | 6.3% |
| 2nd quarter | ||||
| Fagron | 26.0% | 29.2% | 6.3% | 9.0% |
| Arseus | 13.0% | 14.4% | 3.9% | 5.2% |
| 1 st half |
||||
| Fagron | 29.7% | 31.7% | 7.2% | 8.8% |
| Arseus | 15.3% | 16.1% | 5.0% | 5.7% |
| 3rd quarter | ||||
| Fagron | 7.0% | 9.9% | 8.7% | 11.7% |
| Arseus | 4.5% | 6.1% | 5.4% | 7.0% |
| 1 st nine months |
||||
| Fagron | 21.5% | 23.8% | 7.6% | 9.7% |
| Arseus | 11.7% | 12.8% | 5.1% | 6.1% |
| 4th quarter | ||||
| Fagron | 14.5% | 17.1% | 12.4% | 14.9% |
| Arseus | 9.7% | 11.0% | 8.6% | 9.9% |
| 2012 | ||||
| Fagron | 19.4% | 21.8% | 8.7% | 10.9% |
| Arseus | 11.1% | 12.2% | 6.0% | 7.1% |
2/3
In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.
For more information:
Constantijn van Rietschoten Director of Corporate Communications +31 88 33 11 222 (office) +31 6 536 91 585 (mobile) [email protected]
Profile of Arseus
Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the healthcare sector in 30 countries around the world. Arseus has four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products and medical ICT solutions. The Belgian company Arseus NV is located in Waregem and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.